Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

XOMA Royalty Stock News

XOMANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$25.00

0.612.50%

At close: -

$25.00

0.000.00%

After Hours: 4:02 PM EDT

XOMA Royalty (XOMA) Forecast

News

Earnings XOMA Royalty (XOMA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest XOMA Royalty Stock News | NASDAQ:XOMA | Benzinga

Get the latest news on XOMA Royalty stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on XOMA Royalty performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, May 28, 2025

XOMA Royalty Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk

Tuesday, May 27, 2025

XOMA Royalty Purchases Future Mezagitamab Roy...
Benzinga Newsdesk

Thursday, April 17, 2025

Benchmark Initiates Coverage On XOMA Royalty ...
Benzinga Newsdesk

Friday, March 28, 2025

The Analyst Verdict: XOMA Royalty In The Eyes Of 4 Experts
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk

Wednesday, March 19, 2025

HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk

Monday, March 17, 2025

XOMA Q4 2024 GAAP EPS $(0.45) Misses $(0.30) ...
Benzinga Newsdesk

Tuesday, February 25, 2025

Ligand Pharmaceuticals Closed A Royalty Finan...
Benzinga Newsdesk

Monday, February 03, 2025

Forecasting The Future: 5 Analyst Projections For XOMA Royalty
Benzinga Insights
HC Wainwright & Co. Maintains Buy on XOMA Roy...
Benzinga Newsdesk

Tuesday, January 07, 2025

HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk

Friday, December 13, 2024

HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk

Tuesday, December 03, 2024

A Glimpse Into The Expert Outlook On XOMA Royalty Through 4 Analysts
Benzinga Insights
HC Wainwright & Co. Maintains Buy on XOMA Roy...
Benzinga Newsdesk

Monday, December 02, 2024

HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk
XOMA Royalty shares are trading higher after ...
Benzinga Newsdesk
XOMA Royalty Said It Owns An Economic Interes...
Benzinga Newsdesk

Thursday, November 07, 2024

XOMA Q3 2024 GAAP EPS $(1.59) Misses $(0.44) ...
Benzinga Newsdesk

Wednesday, October 23, 2024

HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk

Tuesday, October 22, 2024

Twist Bioscience Enters Royalty Purchase Agre...
Benzinga Newsdesk

Monday, September 23, 2024

XOMA Royalty Says Zevra Therapeutics Received...
Benzinga Newsdesk
XOMA Announces $0.53906 for Series A, $0.5234...
Benzinga Newsdesk

Friday, September 20, 2024

HC Wainwright & Co. Reiterates Buy on XOMA Ro...
Benzinga Newsdesk

Thursday, August 15, 2024

HC Wainwright & Co. Maintains Buy on XOMA Roy...
Benzinga Newsdesk

Tuesday, August 13, 2024

XOMA Q2 2024 GAAP EPS $0.84 Beats $(0.27) Est...
Benzinga Newsdesk

Tuesday, July 09, 2024

FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base
Vandana Singh
Demystifying XOMA: Insights From 5 Analyst Reviews
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk

Wednesday, June 12, 2024

XOMA Disclosed It Had Received An $8.1M Miles...
Benzinga Newsdesk

Friday, May 31, 2024

Peeling Back The Layers: Exploring XOMA Through Analyst Insights
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk

Thursday, May 09, 2024

XOMA Q1 2024 GAAP EPS $(0.86) Misses $(0.81) ...
Benzinga Newsdesk

Friday, May 03, 2024

Lexicon Pharmaceuticals Reports Q1 Loss, Misses Revenue Estimates
Zacks

Wednesday, May 01, 2024

HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk

Tuesday, April 30, 2024

Xoma Has Acquired An Economic Interest In Thr...
Benzinga Newsdesk

Monday, April 29, 2024

Cracking The Code: Understanding Analyst Reviews For XOMA
Benzinga Insights
Leerink Partners Initiates Coverage On XOMA w...
Benzinga Newsdesk

Thursday, April 25, 2024

Xoma Earns $9M As FDA Grants Accelerated Appr...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk

Tuesday, March 19, 2024

XOMA Corp Entered Into A Merger Agreement To ...
Benzinga Newsdesk

Monday, March 11, 2024

HC Wainwright & Co. Maintains Buy on XOMA, Ma...
Benzinga Newsdesk

Friday, March 08, 2024

Recap: XOMA Q4 Earnings
Benzinga Insights
XOMA FY GAAP EPS $(4.04) May Not Be Comparabl...
Benzinga Newsdesk

Friday, February 16, 2024

HC Wainwright & Co. Reiterates Buy on XOMA, M...
Benzinga Newsdesk
Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma
Vandana Singh
XOMA Enters Agreement To Acquire Kinnate Biop...
Benzinga Newsdesk
Trading Halt: Halted at 7:55:00 a.m. ET - Tra...
Benzinga Newsdesk

Thursday, January 18, 2024

Talphera Announces $26M Capital Commitment Th...
Benzinga Newsdesk
XOMA Expands Its Commercial Royalty And Miles...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investors Events
Pre market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved